The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies

0 Comments
The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies

Cetuximab has a longtime function within the therapy of sufferers with recurrent/metastatic colorectal most cancers and head and neck squamous cell most cancers (HNSCC). Nonetheless, the long-term effectiveness of cetuximab has been restricted by the event of acquired resistance, resulting in tumor relapse. Against this, immunotherapies can elicit long-term tumor regression, however the general response […]